NOVOEIGHT 250 IU, powder and solvent for solution for injection bottle, 4 ml
Active ingredients: Turoctocog alfa
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOVOEIGHT 250 UI, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 4 ml avec adaptateur(s) pour flacon
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jul 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66990599CIP75857395CIP133400958573958Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TUROCTOCOG ALFApoudre | 250 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.